212 related articles for article (PubMed ID: 4276374)
21. On certain effects of dopaminergic agents in pentylenetetrazol convulsions.
Lazarova MB; Roussinov KS
Acta Physiol Pharmacol Bulg; 1978; 4(3):50-5. PubMed ID: 751452
[TBL] [Abstract][Full Text] [Related]
22. Anorexigenic effects of d-amphetamine and l-DOPA in the rat.
Sanghvi IS; Singer G; Friedman E; Gershon S
Pharmacol Biochem Behav; 1975; 3(1):81-6. PubMed ID: 1129359
[TBL] [Abstract][Full Text] [Related]
23. Role of catecholaminergic mechanisms in the expression of the morphine abstinence syndrome in rats.
Herz A; Bläsig J; Papeschi R
Psychopharmacologia; 1974; 39(2):121-43. PubMed ID: 4476079
[No Abstract] [Full Text] [Related]
24. Significance of dopamine receptor activity in dl-p-methoxyamphetamine- and d-amphetamine-induced locomotor activity.
Tseng LF; Loh HH
J Pharmacol Exp Ther; 1974 Jun; 189(3):717-24. PubMed ID: 4858403
[No Abstract] [Full Text] [Related]
25. Effect of L-DOPA analogues in Sidman avoidance performance in mice.
Thut PD
Life Sci; 1977 Aug; 21(3):423-31. PubMed ID: 895374
[No Abstract] [Full Text] [Related]
26. Release of brain dopamine as the probable mechanism for the hypothermic effect of D-amphetamine.
Yehuda S; Wurtman RJ
Nature; 1972 Dec; 240(5382):477-8. PubMed ID: 4565945
[No Abstract] [Full Text] [Related]
27. Narcotic withdrawal like mouse jumping produced by amphetamine and L-DOPA.
Lal H; Colpaert FC; Laduron P
Eur J Pharmacol; 1975 Jan; 30(1):113-6. PubMed ID: 1168136
[TBL] [Abstract][Full Text] [Related]
28. Circling behavior following systemic d-amphetamine administration: potential noradrenergic and dopaminergic involvement.
Kokkinidis L; Anisman H
Psychopharmacology (Berl); 1979 Jun; 64(1):45-54. PubMed ID: 113831
[TBL] [Abstract][Full Text] [Related]
29. Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine.
Avale ME; Nemirovsky SI; Raisman-Vozari R; Rubinstein M
J Neurosci Res; 2004 Oct; 78(2):289-96. PubMed ID: 15378510
[TBL] [Abstract][Full Text] [Related]
30. Effects of an atypical barbiturate (valofan) on spontaneous and stimulated locomotor activity and on brain serotonin metabolism in mice.
Traversa U; Puppini P; Florio C; Vertua R
Farmaco Sci; 1987 Oct; 42(10):755-66. PubMed ID: 2449358
[TBL] [Abstract][Full Text] [Related]
31. Effects of d-amphetamine sulfate given to pregnant mice on activity and on catecholamines in the brains of offspring.
Middaugh LD; Blackwell LA; Santos CA; Zemp JW
Dev Psychobiol; 1974 Sep; 7(5):429-38. PubMed ID: 4426470
[No Abstract] [Full Text] [Related]
32. Responsiveness to d-amphetamine in lead-exposed rats as measured by steady state levels of catecholamines and locomotor activity.
Rafales LS; Greenland RD; Zenick H; Goldsmith M; Michaelson IA
Neurobehav Toxicol Teratol; 1981; 3(3):363-7. PubMed ID: 7290291
[TBL] [Abstract][Full Text] [Related]
33. Effects of d-amphetamine and disruption of 5-hydroxytryptaminergic neuronal systems on the synthesis of dopamine in selected regions of the rat brain.
Lyness WH; Demarest KT; Moore KE
Neuropharmacology; 1980 Sep; 19(9):883-9. PubMed ID: 6448358
[No Abstract] [Full Text] [Related]
34. Deletion of Melanin-Concentrating Hormone Receptor-1 gene accentuates D-amphetamine-induced psychomotor activation but neither the subsequent development of sensitization nor the expression of conditioned activity in mice.
Tyhon A; Lakaye B; Grisar T; Tirelli E
Pharmacol Biochem Behav; 2008 Feb; 88(4):446-55. PubMed ID: 17996928
[TBL] [Abstract][Full Text] [Related]
35. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
Dhir A; Kulkarni SK
Brain Res Bull; 2007 Sep; 74(1-3):58-65. PubMed ID: 17683790
[TBL] [Abstract][Full Text] [Related]
36. [Semax potentiates effects of D-amphetamine on the level of extracellular dopamine in the Sprague-Dawley rat striatum and on the locomotor activity of C57BL/6 mice].
Eremin KO; Saransaari P; Oja S; Raevskiĭ KS
Eksp Klin Farmakol; 2004; 67(2):8-11. PubMed ID: 15188751
[TBL] [Abstract][Full Text] [Related]
37. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
Peterson DW; Sparber SB
J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
[No Abstract] [Full Text] [Related]
38. Evidence of serotonin-dopamine involvement in the inhibition of d-amphetamine stereotypy and appearance of stereotyped movements found respectively after acute and long-term treatment with morphine and methadone in rats.
Cervo L; Romandini S; Samanin R
Life Sci; 1981 Dec; 29(25):2585-91. PubMed ID: 6459509
[No Abstract] [Full Text] [Related]
39. An inhibitory role for brain serotonin-containing systems in the locomotor effects of d-amphetamine.
Hollister AS; Breese GR; Kuhn CM; Cooper BR; Schanberg SM
J Pharmacol Exp Ther; 1976 Jul; 198(1):12-22. PubMed ID: 132524
[TBL] [Abstract][Full Text] [Related]
40. A comparison of the locomotor stimulant properties of amantadine and l- and d-amphetamine in mice.
Thornburg JE; Moore KE
Neuropharmacology; 1972 Sep; 11(5):675-82. PubMed ID: 4151250
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
